Table 2.
Clinical features of the 24 COVID-19 patients.
| ID | Age | Sex | Race/Ethnicity | Mobility Issues ‡ | Selfcare Issues ‡ | Activity Issues ‡ | Hospitalized | Days Till visit § | IgG | ApoE Genotype | Neuro Symptoms | Comorbidity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 34 | F | AI/L | 2 | 1 | 1 | No | 36 | 4.2 | ε3,ε3 | DV | LD |
| 2 † | 69 | M | W | 3 | 3 | 3 | No | 62 | 8.3 | ε3,ε3 | M/C | HT,LD,O |
| 3 | 38 | F | Asian | 2 | 2 | 2 | Yes | 103 | 8.6 | ε3,ε3 | H | AID, DM,O |
| 4 † | 59 | M | W | 3 | 3 | 3 | Yes | 80 | 7.5 | ε3,ε3 | M/C | HT,LD |
| 5 | 33 | F | W/L | 2 | 1 | 3 | No | 97 | 3.3 | ε3,ε3 | M/C | HT |
| 6 | 43 | F | B/L | 2 | 1 | 3 | Yes | 99 | 9.4 | ε3,ε4 | M/C | HT,LD,O |
| 7 | 46 | F | W/L | 2 | 2 | 3 | Yes | 95 | 5.9 | ε3,ε4 | M/C | DM,O |
| 8 | 43 | F | W | 2 | 2 | 2 | No | 40 | 9.1 | ε3,ε3 | M/C | O |
| 9 | 30 | F | W | 1 | 2 | 3 | No | 38 | 2 | ε2,ε3 | None | |
| 10 | 37 | F | W | 1 | 1 | 1 | No | 30 | 0.4 | ε3,ε3 | None | |
| 11 | 30 | F | W | 1 | 1 | 1 | No | 31 | 3.9 | ε3,ε3 | None | |
| 12 | 43 | F | W | 3 | 2 | 3 | No | 52 | 1.1 | ε3,ε4 | None | |
| 13 | 35 | F | W | 2 | 1 | 2 | No | 41 | 8.8 | ε3,ε4 | None | |
| 14 | 30 | F | W | 2 | 1 | 1 | No | 44 | 6.1 | ε3,ε4 | None | |
| 15 | 66 | F | W | 3 | 2 | 3 | No | 49 | 8.4 | ε3,ε3 | None | LD |
| 16 | 40 | F | B | 1 | 1 | 1 | No | 38 | 4.9 | ε3,ε4 | None | O |
| 17 | 33 | F | W | 1 | 2 | 1 | No | 60 | 3.5 | ε3,ε3 | None | O |
| 18 | 67 | M | W | 2 | 1 | 2 | No | 64 | 2.6 | ε4,ε4 | None | O |
| 19 | 43 | F | B | 1 | 3 | 2 | No | 70 | 7.3 | ε3,ε3 | None | HT |
| 20 | 59 | F | W | 2 | 2 | 2 | No | 60 | 0.3 | ε2,ε3 | None | |
| 21 | 40 | F | W | 2 | 1 | 2 | No | 60 | 7.2 | ε3,ε3 | None | |
| 22 | 52 | M | Dc/L | 3 | 3 | 3 | Yes | 88 | 5.8 | ε3,ε3 | None | DM |
| 23 | 65 | M | Dc/L | 3 | 3 | 3 | Yes | 84 | 6.7 | ε3,ε3 | None | DM,O |
| 24 | 52 | M | Dc/L | 2 | 1 | 1 | Yes | 97 | 4.2 | ε3,ε3 | None |
† Patient 2 was HIV +; all others were HIV-. Patient 4 was intubated; all others did not require intubation. ‡ 1 = none, 2 = some, 3 = bedbound or unable. § Days till visit was defined as days of symptoms before first visit. IgG levels of SARS-CoV-2 IgG < 1.4 were considered negative. Abbreviations used for race/ethnicity, W: White; B: Black; AI: American Indian; L: Latino; Dc = Declined; for neuro-symptoms, DV = Double vision, M/C = Memory/cognition, H = Hallucinations; for comorbidity, LD = Lung Disease, HT = Hypertension, AID = Autoimmune disease, DM = Diabetes, O = Obesity (BMI ≥ 30.0).